Food and Drug Administration

U.S. drug regulator whose standard safety review process is bypassed by the new peptide policy.

“Non-Alcoholic” Drinks Can Still Contain Alcohol, Depending on Where You Live
FDA tentatively approves Dr. Reddy’s generic HIV prevention medicine
FDA and CMS seek state partnerships on health AI oversight
Samsung expands Galaxy Ring sleep apnea detection after FDA authorization
Samsung’s Upgraded Sleep Apnea Feature Arrives on Galaxy Ring and Watch9 in the US
Aeon Biopharma lowers warrant exercise prices, expects $6.2 million
US Analysis Links Energy Drinks to Some Heart Emergencies in Young Adults
Phases Launches Telehealth Platform With Peptide Treatments for Women
Kratom Marketed for Wellness Raises Concerns About Addiction and Other Risks
FDA seeks to withdraw Tavneos approval over alleged trial data manipulation
FDA Warns of Once Upon a Farm Tractor Wheels Choking Hazard
FDA Sets May 1 Decision Date for uniQure’s Huntington’s Gene Therapy
Gentherm introduces ThermAffyx system for patient warming and positioning in robotic surgery
FDA Approves Generic HIV Prevention Shot to Expand Access in Lower-Income Countries
Gene-Editing Stocks Rise on ESGCT Data and FDA Draft Guidance
FDA Delays Decision on Agios’ Mitapivat Application for Sickle Cell Disease
Taurine Shows Promise as a Calming Supplement for Some Mental Health Conditions
Tempus AI Faces Critical Profitability Test Ahead of Monday Earnings Report
RFK Jr. Unilaterally Approves Broad Access to Unapproved Peptide Injections Despite FDA Warnings
New Treatments Offer Hope for Patients with Runaway Bone Disorder F.O.P.
Opinion: Congress Must Act to Restore Independence of Scientific Advisory Committees
FDA and CMS Work Behind the Scenes to Prevent Regulatory Conflict Over State AI Testing